Carevive’s Longitudinal Data

At Carevive, our commitment to enhancing cancer care through data-driven insights is at the core of our mission. Our real-time, longitudinal data set offers comprehensive and up-to-date information on patient experiences throughout their cancer journey.

With over 1,700 patients represented across 26 cancer types, our registry provides a wealth of information from more than 19,000 completed surveys conducted over two years. This rich dataset encompasses over 600,000 unique data points, providing valuable information for analysis and personalized care planning.

One of the key strengths of our approach is seamless integration with the care process. Our surveys are presented to patients by their care teams, ensuring an outstanding survey response rate of 82% or higher for some indications. This compliance underscores the importance of patient engagement in the treatment process.

Carevive’s real-time data empowers care teams with valuable insights, enabling them to make informed decisions, proactively address patient concerns, and optimize treatment plans. Our commitment to advancing cancer care through data excellence sets the stage for continued innovation and improved patient outcomes.

Recent Episodes

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risks can go unnoticed. The central challenge facing hospitals today is not…

As the Patient Monitoring series concludes, the conversation shifts from today’s challenges to tomorrow’s possibilities. This final episode of the five-part Health and Life Sciences at the Edge series looks ahead to what healthcare could become if patient monitoring gets it right. Intel’s Kaeli Tully is joined by Sudha Yellapantula, Senior Researcher at Medical…